Making Sense of Anthropic’s Fight and OpenAI’s Opportunity
Anthropic’s dispute with the Pentagon over ethical uses triggers a contract cancellation and a supply chain risk desi...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesAnthropic’s dispute with the Pentagon over ethical uses triggers a contract cancellation and a supply chain risk desi...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
Digital platforms connect buyers and sellers worldwide, yet taxes struggle to keep up. This article explains why dest...
Axon is set to report Q4 2025 results after the close, as Wall Street weighs software momentum, AI-era bookings, and ...
Tempus AI reported an 83% jump in Q4 revenue to $367 million but failed to hit positive full-year profitability, guid...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Beyond Meat's stock has faced a steep slide, but the plant-based meat story isn’t closed. This guide breaks down the ...
Celebrity chatter around Bond casting isn’t just gossip—it’s a real-world case study in how entertainment rumors can ...
As Uber eyes profitability, a multi-year bull case hinges on margin expansion and stronger bookings. This analysis ou...
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...
OpenAI's ongoing losses highlight the high-cost path of AI leadership. This article explains why two blue-chip AI sto...